Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 750 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cabaletta Bio, Inc.
Market Cap
$326.11M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$324.71M
Net Profit Margin
-81.76%
TTM Avg
-64.66%
3Y Avg
-75.38%
5Y Avg
-73.80%
Market Cap
$324.01M
Net Profit Margin
-214.74%
TTM Avg
-178.01%
3Y Avg
-157.31%
5Y Avg
-157.31%
Market Cap
$321.85M
Net Profit Margin
-29.15%
TTM Avg
-23.79%
3Y Avg
-17.88%
5Y Avg
-22.05%
Market Cap
$320.74M
Net Profit Margin
-56.96%
TTM Avg
-82.06%
3Y Avg
-78.03%
5Y Avg
-79.87%
Market Cap
$333.02M
Net Profit Margin
69.34%
TTM Avg
-109.76%
3Y Avg
-150.31%
5Y Avg
-135.75%
Market Cap
$317.88M
Net Profit Margin
-289.44%
TTM Avg
-294.02%
3Y Avg
-409.64%
5Y Avg
-336.94%
Market Cap
$307.39M
Net Profit Margin
-145.12%
TTM Avg
-145.12%
3Y Avg
-145.12%
5Y Avg
-145.12%
Market Cap
$349.40M
Net Profit Margin
-184.60%
TTM Avg
-1235.34%
3Y Avg
-1300.41%
5Y Avg
-438.85%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $326.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $324.71M | -81.76% | -64.66% | -75.38% | -73.80% |
| CapsoVision, Inc. (CV)vs › | $324.01M | -214.74% | -178.01% | -157.31% | -157.31% |
| Sanara MedTech Inc. (SMTI)vs › | $321.85M | -29.15% | -23.79% | -17.88% | -22.05% |
| Avita Medical Inc. (RCEL)vs › | $320.74M | -56.96% | -82.06% | -78.03% | -79.87% |
| Agenus Inc. (AGEN)vs › | $333.02M | 69.34% | -109.76% | -150.31% | -135.75% |
| C4 Therapeutics, Inc. (CCCC)vs › | $317.88M | -289.44% | -294.02% | -409.64% | -336.94% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $307.39M | -145.12% | -145.12% | -145.12% | -145.12% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.40M | -184.60% | -1235.34% | -1300.41% | -438.85% |
| Benitec Biopharma Inc. (BNTC)vs › | $299.52M | 0.00% | 0.00% | -6520.67% | -12425.66% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
